Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 8 de 8
1.
Inflamm Res ; 72(9): 1919-1932, 2023 Sep.
Article En | MEDLINE | ID: mdl-37725105

OBJECTIVE: Nafamostat mesilate (NM), a synthetic broad-spectrum serine protease inhibitor, has been commonly used for treating acute pancreatitis (AP) and other inflammatory-associated diseases in some East Asia countries. Although the potent inhibitory activity against inflammation-related proteases (such as thrombin, trypsin, kallikrein, plasmin, coagulation factors, and complement factors) is generally believed to be responsible for the anti-inflammatory effects of NM, the precise target and molecular mechanism underlying its anti-inflammatory activity in AP treatment remain largely unknown. METHODS: The protection of NM against pancreatic injury and inhibitory effect on the NOD-like receptor protein 3 (NLRP3) inflammasome activation were investigated in an experimental mouse model of AP. To decipher the molecular mechanism of NM, the effects of NM on nuclear factor kappa B (NF-κB) activity and NF-κB mediated NLRP3 inflammasome priming were examined in lipopolysaccharide (LPS)-primed THP-1 cells. Additionally, the potential of NM to block the activity of histone deacetylase 6 (HDAC6) and disrupt the association between HDAC6 and NLRP3 was also evaluated. RESULTS: NM significantly suppressed NLRP3 inflammasome activation in the pancreas, leading to a reduction in pancreatic inflammation and prevention of pancreatic injury during AP. NM was found to interact with HDAC6 and effectively inhibit its function. This property allowed NM to influence HDAC6-dependent NF-κB transcriptional activity, thereby blocking NF-κB-driven transcriptional priming of the NLRP3 inflammasome. Furthermore, NM exhibited the potential to interfere the association between HDAC6 and NLRP3, impeding HDAC6-mediated intracellular transport of NLRP3 and ultimately preventing NLRP3 inflammasome activation. CONCLUSIONS: Our current work has provided valuable insight into the molecular mechanism underlying the immunomodulatory effect of NM in the treatment of AP, highlighting its promising application in the prevention of NLRP3 inflammasome-associated inflammatory pathological damage.


Inflammasomes , Pancreatitis , Mice , Animals , Inflammasomes/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Pancreatitis/chemically induced , Pancreatitis/drug therapy , Pancreatitis/prevention & control , NF-kappa B/metabolism , Ceruletide/adverse effects , NLR Proteins , Histone Deacetylase 6/therapeutic use , Acute Disease , Inflammation/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use
2.
Front Cell Infect Microbiol ; 11: 713873, 2021.
Article En | MEDLINE | ID: mdl-34552884

Cryptosporidium is an enteric apicomplexan parasite, which can infect multiple mammals including livestock and wildlife. Tibetan Antelope (Pantholops hodgsonii) is one of the most famous wildlife species, that belongs to the first class protected wild animals in China. However, it has not been known whether Tibetan Antelope is infected with Cryptosporidium so far. The objective of the present study was to determine the prevalence and characterization of Cryptosporidium species infection in Tibetan Antelope and the corresponding species by using molecular biological method. In the current study, a total of 627 fecal samples were randomly collected from Tibetan Antelope in the Tibet Autonomous Region (2019-2020), and were examined by PCR amplification of the small subunit ribosomal RNA (SSU rRNA) gene. Among 627 samples, 19 (3.03%, 19/627) were examined as Cryptosporidium-positive, with 7 (2.33%, 7/300) in females and 12 (3.67%, 12/327) in males. The analysis of SSU rRNA gene sequence suggested that only two Cryptosporidium species, namely, C. xiaoi and C. ubiquitum, were identified in this study. This is the first evidence for an existence of Cryptosporidium in Tibetan Antelope. These findings extend the host range for Cryptosporidium spp. and also provide important data support for prevention and control of Cryptosporidium infection in Tibetan Antelope.


Antelopes , Cryptosporidiosis , Cryptosporidium , Animals , China/epidemiology , Cryptosporidiosis/epidemiology , Cryptosporidium/genetics , Feces , Female , Male , Phylogeny , Prevalence , Tibet
3.
Inflammation ; 44(5): 2091-2105, 2021 Oct.
Article En | MEDLINE | ID: mdl-34080089

Baicalin has been reported to have ameliorative effects on nerve-induced hypoxic ischemia injury; however, its role in the NLRP3 inflammasome-dependent inflammatory response during cerebral ischemia-reperfusion remains unclear. To investigate the molecular mechanisms involved in baicalin alleviating cerebral ischemia-reperfusion injury, we investigated the AMPK signaling pathway which regulates NLRP3 inflammasome activity. SD rats were treated with baicalin at doses of 100 mg/kg and 200 mg/kg, respectively, after middle cerebral artery occlusion at 2 h and reperfusion for 24 h (MCAO/R). MCAO/R treatment significantly increased cerebral infarct volume, changed the ultrastructure of nerve cells, and activated the NLRP3 inflammasome, manifesting as significantly increased expression of NLRP3, ASC, cleaved caspase-1, IL-1ß, and IL-18. Our results demonstrated that baicalin treatment effectively reversed these phenomena in a dose-dependent manner. Additionally, inhibition of NLRP3 expression was found to promote the neuroprotective effects of baicalin on cortical neurons. Furthermore, baicalin remarkably increased the expression of p-AMPK following oxygen glucose deprivation/reperfusion (OGD/R). The expression of the NLRP3 inflammasome was also increased when the AMPK pathway was blocked by compound C. Taken together, our findings reveal that baicalin reduces the activity of the NLRP3 inflammasome and consequently inhibits cerebral ischemia-reperfusion injury through activation of the AMPK signaling pathway.


AMP-Activated Protein Kinase Kinases/antagonists & inhibitors , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Brain Ischemia/metabolism , Flavonoids/therapeutic use , NLR Family, Pyrin Domain-Containing 3 Protein/antagonists & inhibitors , Reperfusion Injury/metabolism , AMP-Activated Protein Kinase Kinases/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Brain Ischemia/drug therapy , Cells, Cultured , Flavonoids/pharmacology , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Neurons/drug effects , Neurons/metabolism , Pyroptosis/drug effects , Pyroptosis/physiology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/drug therapy , Signal Transduction/drug effects , Signal Transduction/physiology
4.
Zhongguo Zhong Yao Za Zhi ; 42(22): 4436-4440, 2017 Nov.
Article Zh | MEDLINE | ID: mdl-29318848

In this paper, we make a report on new records of medicinal plants in Hubei, which include one newly recorded genera and seven newly recorded species and a newly recorded variety. The newly recorded genera is Anoectochilus and its corresponding species is Anoectochilus roxburghii; These newly recorded species are Euphorbia micractina, Astragalus wulingensis, Blumea megacephala, Potentilla saundersiana, Blumea formosana, Lycoris houdyshelii and Colocasia gigantea ; The newly recorded variety is Neottia puberula var. maculata. Among these species, Anoectochilus roxburghii and N. puberula var. maculata are considered as the second-class protection in our country, A. roxburghii is regarded as Endangered(EN)and Astragalus wulingensis is regarded as Critically Endangered (CN) by IUCN. The report of these newly recorded plants borden the distribution and enrich the plant diversity of Hubei.


Asteraceae/classification , Astragalus Plant/classification , Orchidaceae/classification , Plants, Medicinal/classification , China , Colocasia , Lycoris , Plant Dispersal , Potentilla
5.
Biochem Biophys Res Commun ; 457(4): 693-9, 2015 Feb 20.
Article En | MEDLINE | ID: mdl-25619136

Murine fibrosarcoma L929 cells have been used to test efficacy of proinflammatory cytokine TNFα. In the present study, we reported on protective effect of type I collagen gel used as L929 cell culture. L929 cell grew and proliferated well on collagen gel. However, the L929 cells exhibited cobblestone-like morphology which was much different from the spread fusiform shape when cultured on conventional cell dishes as well as the cells tended to aggregate. On conventional cell culture dishes, the cells treated with TNFα became round in shape and eventually died in a necroptotic manner. The cells cultured on collagen gel, however, were completely unaffected. TNFα treatment was reported to induce autophagy in L929 cells on the plastic dish, and therefore we investigated the effect of collagen gel on induction of autophagy. The results indicated that autophagy induced by TNFα treatment was much reduced when the cells were cultured on collagen gel. In conclusion, type I collagen gel protected L929 cell from TNFα-induced cell death.


Collagen Type I/pharmacology , Gels/pharmacology , Protective Agents/pharmacology , Tumor Necrosis Factor-alpha/immunology , Animals , Autophagy/drug effects , Cell Culture Techniques , Cell Death/drug effects , Cell Line, Tumor , Fibrosarcoma/drug therapy , Fibrosarcoma/immunology , Humans , Mice
7.
Bing Du Xue Bao ; 24(4): 312-6, 2008 Jul.
Article Zh | MEDLINE | ID: mdl-18780636

A coxsackievirus B strain was successfully isolated by cells culture from cardiac muscle tissues of a dead Sichuan golden monkey with myocarditis from a zoo of Changchun in China. The isolate was consistent with CVB by morphology, physicochemistry test, animal regression test and RT-PCR. Analysis of VP1 partial gene sequence and detection of mice specific serum IgG showed that the strain isolated was a coxsackievirus B3. It was the first CVB case report in Sichuan golden monkey and the strain isolated was named CVB/SGM-05.


Enterovirus B, Human/isolation & purification , Haplorhini/virology , Animals , Chlorocebus aethiops , Heart/virology , Mice , Reverse Transcriptase Polymerase Chain Reaction , Vero Cells , Viral Structural Proteins/genetics
8.
Beijing Da Xue Xue Bao Yi Xue Ban ; 38(3): 301-4, 2006 Jun 18.
Article Zh | MEDLINE | ID: mdl-16778977

OBJECTIVE: To study the relationship between gene mutation of GTP cyclohydrolase I function region in lanosterine 14 alpha-demethylase (14-DM) DNA sequence and drug resistance of Candida albicans. METHODS: One standard strain and 2 isolate strains of Candida albicans were induced artificially by fluconazole plus albendazole. The gene fragments of the 3 strains and another 2 clinical isolates which were resistant to fluconazol were detected by PCR, and then cloned onto pMD-18T vectors to sequence and analyze the change of gene sequence after the induction. RESULTS: The sequences underwent substantial gene mutations after induction. Some of the mutations resulted in alteration of amino acids. The sequence change and subsequent alteration of amino acids in the tested strains coincided with those in the clinical isolates. CONCLUSION: Gene mutation and alteration of amino acid of 14-DM GTP domain are related to azole-resistance in Candida albicans.


Antifungal Agents/pharmacology , Candida albicans/genetics , Drug Resistance, Fungal/genetics , GTP Cyclohydrolase/genetics , Albendazole/pharmacology , Candida albicans/drug effects , Candida albicans/enzymology , Cloning, Molecular , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Fungal/metabolism , Deoxyribonuclease EcoRI/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Fluconazole/pharmacology , Mutation/drug effects , Sequence Analysis, DNA
...